Superior sagittal sinus thrombosis (SSST) is an uncommon cause of stroke, whose symptoms and clinical course are highly variable. It is frequently associated with a variety of hypercoagulable states. Coagulation abnormalities are commonly seen in patients with hyperthyroidism. To the best of our knowledge, there are few reports on the association between hyperthyroidism and cerebral venous thrombosis. We report on a 31-year-old male patient with a six-year history of hyperthyroidism who developed seizure and mental deterioration. Findings on brain computed tomography (CT) showed multiple hemorrhages in the subcortical area of both middle frontal gyrus and cerebral digital subtraction angiography (DSA) showed irregular intra-luminal filling defects of the superior sagittal sinus. These findings were consistent with hemorrhagic transformation of SSST. Findings on clinical laboratory tests were consistent with hyperthyroidism. In addition, our patient also showed high activity of factors IX and XI. The patient received treatment with oral anticoagulant and prophylthiouracil. His symptoms showed complete improvement. A follow-up cerebral angiography four weeks after treatment showed a recanalization of the SSS. In conclusion, findings of our case indicate that hypercoagulability may contribute to development of SSST in a patient with hyperthyroidism.
INTRODUCTION
Cerebral venous and sinus thrombosis is a rare condition accounting for < 1% of all strokes. 7) Its annual incidence is estimated at three to four cases per one million members of the population, most often affecting young adults and children. 19) In adults, the peak incidence is in their third decade, and approximately 75% of adult patients are female. 5)7) Thrombotic risk factors or direct causes are identified in approximately 85% of patients with cerebral sinus thrombosis. 19) Superior sagittal sinus thrombosis (SSST) is associated with a variety of hypercoagulable, states including Crohn's disease, diabetes insipidus, direct injury to the sinus, iatrogenic causes, malignancy, nephrotic syndrome, oral contraceptives, paroxysmal nocturnal hemoglobinuria, polycythemia, pregnancy, puerperium, systemic lupus erythematosus, and ulcerative colitis. 1)19) Coagulation abnormalities are commonly seen in patients with hyperthyroidism.
6)9)18)
However, the association between hyperthyroidism and cerebral venous thrombosis is poorly understood.
To investigate the possible association between these two clinical conditions, we report on a case of a A B 31-year-old male patient with a six-year history of hyperthyroidism who developed SSST.
CASE REPORT
A 31-year-old male patient was admitted to our institute with seizure, headache, and mental deterioration.
During the recent six years, the patient had been prescribed methimazole for treatment of hyperthyroidism.
However, three months before, the patient had arbitrarily stopped taking the medication. He did not un- 
DISCUSSION
SSST is an uncommon cerebrovascular accident; due to a broad spectrum of symptoms and clinical courses, a diagnosis is still frequently overlooked or delayed.
7)
The average delay from the onset of symptoms to the diagnosis is seven days. 8) In addition, approximately 15% of cases of SSST are considered to be idiopathic. 19) Although coagulation disturbances are reported in hyperthyroidism, an association between hyperthyroidism and cerebral venous thrombosis has not been well 
